|LETTER TO THE EDITOR
|Year : 2013 | Volume
| Issue : 2 | Page : 86
Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis
Neeraj Pandey, Vandana Dwivedi
Department of Vitreo-Retina and Uvea, Aravind Eye Hospital, Hyderabad, India
|Date of Web Publication||15-Feb-2013|
Department of Vitreo-Retina and Uvea, Aravind Eye Hospital Pvt. Ltd. 12-2-824, Santosh Nagar Colony, Mehdipatnam, Hyderabad - 500 028
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Pandey N, Dwivedi V. Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis. Indian J Ophthalmol 2013;61:86
We read the article by Shah et al.  with great interest. At first, we would like to congratulate the authors for a very nice case reported here. We have a few comments to make on this case report.
- Inflammatory choroidal neovascular membrane (CNVM) is not so uncommon to be seen as reported in the case and it may be associated with toxoplasmosis, tuberculosis, etc. ,
- Subretinal fluid (SRF) mentioned in [Figure 1] (color picture) is not very well supported by [Figure 2] where optical coherence tomography (OCT) does not show any SRF. Instead, it does show scarring.
- Blocked fluorescence seen in [Figure 2] may be due to the pigmentation around the lesion which may be a sign of longstanding lesion with retinal pigment epithelium (RPE) alteration.
- Hyperfluorescence seen in [Figure 2] may be staining of scar as it is a late phase angiogram picture. No early phase picture is shown in the support of early leak of CNVM.
- [Figure 3] is shown in the article as no leak with regressed CNVM, which is an early phase picture and it may take stain in late phase as in [Figure 2] if it was only scar. It is well supported by the OCT showing shadowing of the reflectivity behind the scar.
- Both the OCTs shown in [Figure 2] and [Figure 3] are probably not passing through the same place, so we cannot compare the reflectivity and shadowing of these two pictures.
| References|| |
Shah NJ, Shah UN. Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis. Indian J Ophthalmol 2011;59:318-9.
Adan A, Mateo C, Wolley-Dod C. Surgery for subfoveal choroidal neovascularization in toxoplasmic retinochoroiditis. Am J Ophthalmol 2003;135:386-7.
Chung YM, Yeh TS, Sheu SJ, Liu JH. Macular subretinal neovascularization in choroidal tuberculosis. Ann Ophthalmol 1989;21:225-9.